|
1
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ramalingam SS, Owonikoko TK and Khuri FR:
Lung cancer: New biological insights and recent therapeutic
advances. CA Cancer J Clin. 61:91–112. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Aisner DL and Marshall CB: Molecular
pathology of non-small cell lung cancer: A practical guide. Am J
Clin Pathol. 138:332–346. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lozano R, Naghavi M, Foreman K, Lim S,
Shibuya K, Aboyans V, Abraham J, Adair T, Aggarwal R, Ahn SY, et
al: Global and regional mortality from 235 causes of death for 20
age groups in 1990 and 2010: A systematic analysis for the Global
Burden of Disease Study 2010. Lancet. 380:2095–2128. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Fedor-Chaiken M, Deschenes RJ and Broach
JR: SRV2, a gene required for RAS activation of adenylate cyclase
in yeast. Cell. 61:329–340. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Field J, Vojtek A, Ballester R, Bolger G,
Colicelli J, Ferguson K, Gerst J, Kataoka T, Michaeli T, Powers S,
et al: Cloning and characterization of CAP, the S. cerevisiae gene
encoding the 70 kd adenylyl cyclase-associated protein. Cell.
61:319–327. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Matviw H, Yu G and Young D: Identification
of a human cDNA encoding a protein that is structurally and
functionally related to the yeast adenylyl cyclase-associated CAP
proteins. Mol Cell Biol. 12:5033–5040. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Freeman NL, Chen Z, Horenstein J, Weber A
and Field J: An actin monomer binding activity localizes to the
carboxyl-terminal half of the Saccharomyces cerevisiae
cyclase-associated protein. J Biol Chem. 270:5680–5685. 1995.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Moriyama K and Yahara I: Human CAP1 is a
key factor in the recycling of cofilin and actin for rapid actin
turnover. J Cell Sci. 115:1591–1601. 2002.PubMed/NCBI
|
|
10
|
Hubberstey AV and Mottillo EP:
Cyclase-associated proteins: CAPacity for linking signal
transduction and actin polymerization. FASEB J. 16:487–499. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Loisel TP, Boujemaa R, Pantaloni D and
Carlier MF: Reconstitution of actin-based motility of Listeria and
Shigella using pure proteins. Nature. 401:613–616. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yu XF, Ni QC, Chen JP, Xu JF, Jiang Y,
Yang SY, Ma J, Gu XL, Wang H and Wang YY: Knocking down the
expression of adenylate cyclase-associated protein 1 inhibits the
proliferation and migration of breast cancer cells. Exp Mol Pathol.
96:188–194. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Fan YC, Cui CC, Zhu YS, Zhang L, Shi M, Yu
JS, Bai J and Zheng JN: Overexpression of CAP1 and its significance
in tumor cell proliferation, migration and invasion in glioma.
Oncol Rep. 36:1619–1625. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Hua M, Yan S, Deng Y, Xi Q, Liu R, Yang S,
Liu J, Tang C, Wang Y and Zhong J: CAP1 is overexpressed in human
epithelial ovarian cancer and promotes cell proliferation. Int J
Mol Med. 35:941–949. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Xie SS, Tan M, Lin HY, Xu L, Shen CX, Yuan
Q, Song XL and Wang CH: Overexpression of adenylate
cyclase-associated protein 1 may predict brain metastasis in
non-small cell lung cancer. Oncol Rep. 33:363–371. 2015. View Article : Google Scholar
|
|
16
|
Xie S, Shen C, Tan M, Li M, Song X and
Wang C: Systematic analysis of gene expression alterations and
clinical outcomes of adenylate cyclase-associated protein in
cancer. Oncotarget. 8:27216–27239. 2017.PubMed/NCBI
|
|
17
|
Tan M, Song X, Zhang G, Peng A, Li X, Li
M, Liu Y and Wang C: Overexpression of adenylate cyclase-associated
protein 1 is associated with metastasis of lung cancer. Oncol Rep.
30:1639–1644. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Rana TM: Illuminating the silence:
Understanding the structure and function of small RNAs. Nat Rev Mol
Cell Biol. 8:23–36. 2007. View Article : Google Scholar
|
|
19
|
Coelho T, Adams D, Silva A, Lozeron P,
Hawkins PN, Mant T, Perez J, Chiesa J, Warrington S, Tranter E, et
al: Safety and efficacy of RNAi therapy for transthyretin
amyloidosis. N Engl J Med. 369:819–829. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Davis ME, Zuckerman JE, Choi CH, Seligson
D, Tolcher A, Alabi CA, Yen Y, Heidel JD and Ribas A: Evidence of
RNAi in humans from systemically administered siRNA via targeted
nanoparticles. Nature. 464:1067–1070. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Tabernero J, Shapiro GI, LoRusso PM,
Cervantes A, Schwartz GK, Weiss GJ, Paz-Ares L, Cho DC, Infante JR,
Alsina M, et al: First-in-humans trial of an RNA interference
therapeutic targeting VEGF and KSP in cancer patients with liver
involvement. Cancer Discov. 3:406–417. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Qi L, Shao W and Shi D; QiLingfeng; Shao W
and Shi D: JAM-2 siRNA intracellular delivery and real-time imaging
by proton-sponge coated quantum dots. J Mater Chem B Mater Biol
Med. 1:654–660. 2013. View Article : Google Scholar
|
|
23
|
Su J, Baigude H, McCarroll J and Rana TM:
Silencing microRNA by interfering nanoparticles in mice. Nucleic
Acids Res. 39:e382011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Sezlev Bilecen D, Rodriguez-Cabello JC,
Uludag H and Hasirci V: Construction of a PLGA based, targeted
siRNA delivery system for treatment of osteoporosis. J Biomater Sci
Polym Ed. 28:1859–1873. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Pisani E, Tsapis N, Paris J, Nicolas V,
Cattel L and Fattal E: Polymeric nano/microcapsules of liquid
perfluorocarbons for ultrasonic imaging: Physical characterization.
Langmuir. 22:4397–4402. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Patnaik S, Sharma AK, Garg BS, Gandhi RP
and Gupta KC: Photoisomerization of azobenzene moiety in
crosslinking. Int J Pharm. 342:184–193. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Cheng J, Teply BA, Sherifi I, Sung J,
Luther G, Gu FX, Levy-Nissenbaum E, Radovic-Moreno AF, Langer R and
Farokhzad OC: Formulation of functionalized PLGA-PEG nanoparticles
for in vivo targeted drug delivery. Biomaterials. 28:869–876. 2007.
View Article : Google Scholar
|
|
28
|
Díaz-López R, Tsapis N, Santin M, Bridal
SL, Nicolas V, Jaillard D, Libong D, Chaminade P, Marsaud V,
Vauthier C, et al: The performance of PEGylated nanocapsules of
perfluorooctyl bromide as an ultrasound contrast agent.
Biomaterials. 31:1723–1731. 2010. View Article : Google Scholar
|
|
29
|
Boyer C, Teo J, Phillips P, Erlich RB,
Sagnella S, Sharbeen G, Dwarte T, Duong HT, Goldstein D, Davis TP,
et al: Effective delivery of siRNA into cancer cells and tumors
using well-defined biodegradable cationic star polymers. Mol Pharm.
10:2435–2444. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Byrne FL, Yang L, Phillips PA, Hansford
LM, Fletcher JI, Ormandy CJ, McCarroll JA and Kavallaris M:
RNAi-mediated stathmin suppression reduces lung metastasis in an
orthotopic neuroblastoma mouse model. Oncogene. 33:882–890. 2014.
View Article : Google Scholar
|
|
31
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
32
|
van der Weij JP, van der Veen CJ, de Vries
E and Cats A: The use of a peroxidase-anti-peroxidase complex for
the visualization of monoclonal antibodies on the ultrastructural
level. Clin Exp Immunol. 54:819–826. 1983.PubMed/NCBI
|
|
33
|
McCarroll JA, Gan PP, Liu M and Kavallaris
M: betaIII-tubulin is a multifunctional protein involved in drug
sensitivity and tumorigenesis in non-small cell lung cancer. Cancer
Res. 70:4995–5003. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
De Rosa G and Salzano G: PLGA microspheres
encapsulating siRNA. Methods Mol Biol. 1218:43–51. 2015. View Article : Google Scholar
|
|
35
|
Zhao Y, Zheng C, Zhang L, Chen Y, Ye Y and
Zhao M: Knockdown of STAT3 expression in SKOV3 cells by
biodegradable siRNA-PLGA/CSO conjugate micelles. Colloids Surf B
Biointerfaces. 127:155–163. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Yamazaki K, Takamura M, Masugi Y, Mori T,
Du W, Hibi T, Hiraoka N, Ohta T, Ohki M, Hirohashi S, et al:
Adenylate cyclase-associated protein 1 overexpressed in pancreatic
cancers is involved in cancer cell motility. Lab Invest.
89:425–432. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Frede A, Neuhaus B, Klopfleisch R, Walker
C, Buer J, Müller W, Epple M and Westendorf AM: Colonic gene
silencing using siRNA-loaded calcium phosphate/PLGA nanoparticles
ameliorates intestinal inflammation in vivo. J Control Release.
222:86–96. 2016. View Article : Google Scholar
|
